Skip to main content
OpenTrials
Completed

NCT Number: NCT01589900

Identification the Expression of Sox2 in Colorectal Cancer Tissues

Sox2 has been studied in several types of human solid tumors. The investigators found that Sox2 had higher expression level in colorectal cancer and metastatic tissues than normal tissues. So the investigators assumed that whether Sox2 plays an important role in the progression and migration of colon cancer.

Completed

Looking for future studies?

Notify Me

Key information

About this study

In our study, we examined Sox2 expression in archived human colon cancer tissues and found that its Sox2 expression correlates with reduced patient survival, increased tumor grade and metastasis probability.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of colorectal cancer

Exclusion criteria

  • Clinical diagnosis characteristics not exactly described in the patients information

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Official study title

The Role of Sox2 in Tumor Genesis and Migration in Colorectal Cancer

Important dates

Study start
2005
Primary completion
2006
Study completion
2012
First posted
May 2, 2012
Registry last updated
May 3, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.